Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Langhua Pharmaceutical provides comprehensive CDMO services covering R&D to commercial supply of small molecule APIs and finished dosage forms. The company has passed multiple international regulatory inspections including FDA, WHO, EDQM, ANVISA, NMPA. It supports global clients with GMP-compliant manufacturing and has contributed to over twenty new drug launches across oncology, HIV/AIDS, diabetes and cardiovascular fields.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Langhua Pharmaceutical.